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vps35 mutants of Saccharomyces cerevisiae exhibit severe defects in the localization of car-
boxypeptidase Y, a soluble vacuolar hydrolase. We have cloned the wild-type VPS35 gene
by complementation of the vacuolar protein sorting defect exhibited by the vps35-17 mutant.
Sequence analysis revealed an open reading frame predicted to encode a protein of 937
amino acids that lacks any obvious hydrophobic domains. Subcellular fractionation studies
indicated that 80% of Vps35p peripherally associates with a membranous particulate cell
fraction. The association of Vps35p with this fraction appears to be saturable; when over-
produced, the vast majority of Vps35p remains in a soluble fraction. Disruption of the
VPS35 gene demonstrated that it is not essential for yeast cell growth. However, the null
allele of VPS35 results in a differential defect in the sorting of vacuolar carboxypeptidase
Y (CPY), proteinase A (PrA), proteinase B (PrB), and alkaline phosphatase (ALP). proCPY
was quantitatively missorted and secreted by Avps35 cells, whereas almost all of proPrA,
proPrB, and proALP were retained within the cell and converted to their mature forms,
indicating delivery to the vacuole. Based on these observations, we propose that alternative
pathways exist for the sorting and/or delivery of proteins to the vacuole.
INTRODUCTION
Eucaryotic cells contain a number of distinct compart-
ments characterized largely by the unique set of proteins
residing within them. This high degree of organization
requires specific mechanisms to sort and deliver proteins
from their site of synthesis in the cytoplasm to their
final intracellular or extracellular destination. The path-
way for proteins destined for the lysosomal/vacuolar
compartment of eukaryotic cells represents a well-
studied example of an intracellular protein sorting
pathway (Kornfeld and Mellman, 1989; Klionsky et
al., 1990). Lysosomal proteins, like proteins destined
for secretion, are first translocated across the mem-
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brane of the endoplasmic reticulum and then are
transported to the Golgi complex. Within the Golgi
apparatus, the pathways diverge. Secretory protein
traffic proceeds by a bulk flow, or default mechanism,
to the cell surface, whereas lysosomal proteins contain
additional sorting information that directs their de-
livery to the lysosome (Kornfeld, 1986; Kornfeld and
Mellman, 1989).
In a variety of mammalian cells, the N-linked car-
bohydrate side chains on soluble lysosomal proteins are
modified with mannose-6-phosphate residues that are
recognized by specific membrane receptors that mediate
lysosomal delivery (Kaplan et al., 1977; Kornfeld and
Mellman, 1989). The targeting signals on soluble pro-
teins destined for the lysosome-like vacuole in the yeast
Saccharomyces cerevisiae are not comprised of specific
carbohydrate modifications but instead appear to reside
directly within the polypeptide backbone of these
proteins (Clark et al., 1982; Schwaiger et al., 1982;
Johnson et al., 1987; Valls et al., 1987; Klionsky et al.,
1988).
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Table 1. Strains used in this study
Strain Genotype Reference
S. cerevisiae
SEY6210 MATa leu2-3,112 ura3-52 his3-A200 trpl-A901 lys2-801 suc2-A9 Robinson et al., 1988
SEY6211 MATa leu2-3,112 ura3-52 his3-Av200 trpl-A901 ade2-101 suc2-A9 Robinson et al., 1988
SEY6210.5 MATa/MATa leu2-3,112/leu2-3,112 his3-A200/his3-A\200 Herman et al., 1990
ura3-52/ura3-52 trpl-A901/rpl-A901 suc2-A9/suc2-A9 ADE2/ade2-101 lys2-801/
LYS2
SEY35-17 SEY6210 vps35-17 Robinson et al., 1988
GPY1 135 SEY6211 vps35MI::HIS3 This study
DKY6224 MATa leu2-3,112 ura3-52 his3-A200 trpl-A901 ade2-101 suc2-A9 pep4MI::LEU2 Klionsky et al., 1988
BHY1 1 SEY6211 leu2-3::pBHY11(CPY-Inv LEU2) Horazdovsky, unpublished data
BHY157 SEY35-17 leu2-3::pBHY11(CPY-Inv LEU2) This study
BHY158 BHY1 1 vps35-17::pVPS35-10 (VPS35 TRP1) This study
E. coli
JM1o1 A(lac-pro) supE thi-1 F' traA36 laCIq AM15 proAB Casadaban and Cohen, 1980
MC1066 F- AlacXZY hsr- hsm+ spsL galW galK trpC9830 leuB600 pyrF: :Tn5 Casadaban et al., 1983
JF1754 hsdR metB leuB hisB lac gal McNeil and Friesen, 1981
DH5a F- 48dlacZAM15 endAl hsdRl7(rk Mk+) supE44 thi-1 recAl gyrA96 relAl A(lacZYA- Bethesda Research Laboratories,
argF)U169 deoR X- Gaithersburg, MD
In an attempt to identify cellular components required
for vacuolar protein sorting in S. cerevisiae, several ge-
netic selection procedures have been employed. Each
has resulted in the isolation of mutants that exhibit de-
fects in vacuolar protein processing and/or localization
(Jones, 1977; Bankaitis et al., 1986; Rothman and Ste-
vens, 1986; Robinson et al., 1988; Rothman et al., 1989).
These vacuolar protein sorting (vps) mutants missort
vacuolar enzyme precursors to the cell surface. Together,
these mutants define more than 45 complementation
groups. In addition to the observed sorting defects,
analysis of vacuolar morphology by light and electron
microscopy has revealed that several of the vps mutants
possess abnormal vacuolar structures (Banta et al., 1988).
Based on these morphological studies, the vps mutants
were assigned to three distinct classes. The majority of
the mutants (called class A vps mutants) contains normal
or slightly enlarged vacuole structures. A second class
of mutants, class B, is characterized by the presence of
multiple small vacuole-like organelles. Finally, class C
mutants lack any compartment that resembles a wild-
type vacuole.
Thirty-two mutant alleles of the VPS35 locus were
originally isolated using a gene fusion-based selection
scheme for mutants that missort and secrete a carboxy-
peptidase Y-invertase (CPY-Inv) hybrid protein. vps35
mutant cells also exhibited defects in the sorting of the
authentic soluble vacuolar hydrolase carboxypeptidase
Y (CPY) (Robinson et al., 1988). Light and electron mi-
croscopic analysis revealed that vps35 mutant cells con-
tain morphologically normal vacuoles (class A) (Banta
et al., 1988). This indicates that vps35 cells are competent
for vacuole assembly and suggests that the VPS35 gene
product may be involved in the sorting of only a subset
of vacuolar enzymes.
In an effort to better understand the role of the VPS35
gene product in vacuolar protein sorting and delivery,
we report here on the cloning and sequencing of the
VPS35 gene, the phenotypic consequences of a vps35
null allele, and the identification and localization of the
VPS35 gene product. We describe a simple plate assay
technique that we devised for cloning the VPS35 gene.
This technique should prove generally useful for the
cloning of many other genes that affect the sorting or
retention of proteins in the secretory pathway. Based
on our findings, we suggest that the Vps35 protein
(Vps35p) is a component of a membrane associated
multiprotein complex that is required for the sorting of
only a subset of vacuolar proteins.
MATERIALS AND METHODS
Strains and Media
The S. cerevisiae and Escherichia coli strains used are listed in Table
1. Bacterial strains were grown on standard media (Miller, 1972). Yeast
strains were grown on yeast extract, peptone, dextrose (YPD) medium,
on synthetic medium (SM) supplemented as necessary (Sherman et
al., 1979), or on Wickerham's minimal proline medium (WiMP)
(Wickerham, 1946) supplemented with 0.2% yeast extract (WiMPYE).
Reagents
DNA restriction and modifying enzymes were from either New
England BioLabs (Beverly, MA) or Boehringer Mannheim Biochemicals
(Indianapolis, IN). Zymolyase lOOT was obtained from Seikagako
Kogyo (Tokyo, Japan). 5-Bromo-4-chloro-3-indolyl-,B-D-galactoside
and isopropyl-4-D-thiogalactopyranoside were from Boehringer
Mannheim Biochemicals. The Sequenase sequencing kit was from
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United States Biochemical (Cleveland, OH). Deoxynucleotides and
the Miniprep Plus kit were products of Pharmacia (Piscataway, NJ).
Tran35S label was from ICN (Irvine, CA). All other radiochemicals
and the Multiprime DNA labeling kit were from Amersham (Arlington
Heights, IL). The Elutrap Electro-Separation Chamber was purchased
from Schleicher & Schuell (Keene, NH) and used as instructed by the
manufacturer. GeneScreen was obtained from New England Nuclear
(Boston, MA). Freund's complete and incomplete adjuvants were ob-
tained from GIBCO (Grand Island, NY). All other chemicals including
antiserum to glucose-6-phosphate dehydrogenase were from Sigma
Chemical (St. Louis, MO). Antibodies to Kex2p were a gift from Kyle
Cunningham, and the antisera to CPY, proteinase A (PrA), and alkaline
phosphatase (ALP) were described previously (Klionsky et al., 1988;
Klionsky and Emr, 1989). The antisera to protease B (PrB) was a gen-
erous gift from Elizabeth Jones, Carnegie-Mellon University, Pitts-
burgh, PA.
Yeast Genetics and Transformation
Genetic crosses, sporulation of diploids, and dissection of tetrads were
performed as previously described (Sherman et al., 1979). Yeast
transformations were performed by the method of Ito et al. (1983).
Typically, 1 ,tg of plasmid DNA was added to 100 ml of competent
cells. For integrative transformations, 200 ng of linear DNA fragment
were used together with 10 Ag of circular pBluescript plasmid (Strata-
gene, La Jolla, CA) as carrier DNA. For gene disruption, the 2.7-kb
Nci I/Xba I fragment from pGPY55 (see below) was transformed into
the diploid strain SEY6210.5. His' transformants were sporulated and
the resultant asci dissected. Integrative mapping strains were con-
structed as follows. pVPS35-10 (see below) was linearized with
Asp718I and used to transform BHY11 to Trp+, yielding BHY158.
BHY158 was crossed with BHY157, diploids were selected, sporulated,
and the resultant asci dissected.
Cloning of VPS35 With an Invertase Plate Assay
SEY35-17 cells (vps35-17 leu2-3,112) carrying a plasmid encoding the
CPY-Inv fusion protein (pCYI-50) (Johnson et al., 1987) were trans-
formed with a yeast genomic library contained in a pBR322-based
LEU2/CEN4/ARS1 shuttle vector (a generous gift from Philip Hieter,
Johns Hopkins University School of Medicine, Baltimore, MD), and
Leu+ transformants were selected. Leu+ colonies were replica plated
onto selective SM fructose medium and incubated overnight at 26°C.
An invertase assay solution containing 125 mM sucrose, 100 mM
sodium acetate (pH 5.5), 10 ig/ml horseradish peroxidase, 8 units/
ml glucose oxidase, 2 mM 0-dianisidine Uohnson et al., 1987; Klionsky
et al., 1988) was mixed with an equal volume of a 2.4% agar solution
(at 50°C) and immediately poured over the replica colonies. After 5
min at room temperature, colonies secreting the CPY-Inv fusion protein
turned red (indicating Vps- phenotype), and colonies with internal
invertase activity remained white (Vps+). Plasmids conferring the Vps+
phenotype were isolated from these yeast cells as described previously
(Braus et al., 1985).
Vectors and Plasmid Constructions
E. coli plasmids pBluescript KS(+) and (-) were obtained from Strata-
gene. The E. coli-yeast shuttle vector pPHYC16 has been described
by Herman and Emr (1990) and the 2,u plasmid pBHY10 by Hora-
zdovsky, and Emr, (unpublished data). The HIS3 gene was isolated
from a plasmid kindly provided by E. Phizicky, Dept. of Biochemistry,
University of Rochester, Rochester, NY. The pATH1 vector used in
constructing the trpE-Vps35 fusion protein has been described else-
where (Dieckmann and Tzagoloff, 1985). A 5.8-kb Sph I-Xba I com-
plementing fragment from the originally isolated vps35 complementing
plasmid was subcloned into pPHYC16 to generate pGPY35. Plasmid
pGPY45 was constructed by excising the 3.8-kb Nci I/Sca I fragment
from pGPY35, filling in the Sca I site with Klenow and ligating the
complementing fragment into the Sma I site of pBHY10. The integrative
mapping plasmid, pVPS35-10, was constructed by inserting the Nci
I/Sca I VPS35-containing fragment into the integrative mapping vector
pPHY110 (Herman and Emr, 1990). For the deletion construct
pGPY55, the 2.45-kb SnaBI fragment of pGPY35 was replaced by a
blunt-ended 1.35-kb BamHI/Xho I HIS3 fragment. Recombinant HIS3
plasmids were selected directly in the hisB E. coli strain JF1754 on
M63 minimal medium lacking histidine.
Northern Blot Analysis
For Northern blot analysis, yeast RNA was prepared as previously
described (Zitomer and Hall, 1976) and enriched for poly(A)+ RNA
according to Aviv and Leder (Aviv and Leder, 1972). RNA was sep-
arated on a formaldehyde-agarose gel as in Rave et al. (1979), trans-
ferred to GeneScreen membranes, and hybridizations were as de-
scribed in Thomas (1980). The 2.45-kb SnaBI VPS35 fragment used
as probe was labeled using the Amersham Multiprime kit.
Sequence Analysis
A 2.8-kb Sph I/BamHI and a 3-kb BamHI/Xba I fragment from
pGPY35 were cloned into the E. coli plasmid pBluescript KS(-) to
generate pGP30 and pGP40. Exonuclease III-mung bean nuclease
deletions were performed on both plasmids from both ends of the
inserts as described in the Stratagene Bluescript manual. Double-
stranded DNA from a number of deletion plasmids was isolated from
E. coli strain DH5a using the Miniprep Plus kit from Pharmacia. Plas-
mid DNA was denatured and sequenced using the Sequenase se-
quencing kit (United States Biochemicals). The predicted protein se-
quence of Vps35p was compared with the contents of the NBRF,
Genbank, and EMBL databases, using the FASTA and TFASTA pro-
grams (Pearson and Lipman, 1988) of the University of Wisconsin
Genetics Computer Group sequence analysis package (Devereux et
al., 1984).
Preparation of Vps35p Specific Antisera
A gene fusion between the E. coli trpE gene and VPS35 was constructed
by subcloning a 0.5-kb EcoRV/Cla I fragment encoding amino acids
630-808 of Vps35p into Sma I/Cla I digested pATH1 (Dieckmann
and Tzagoloff, 1985), generating an in-frame fusion gene. The fusion
point was sequenced to ensure correct in-frame fusion. This trpE-
Vps35 fusion protein was induced and prepared as previously de-
scribed by Kleid et al. (1981) with the following modifications: in-
duction was overnight, cells were broken in a freeze-thaw step, and
2% Triton X-100 was used instead of Nonidet P-40. After sodium
dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, the pre-
dominant 55-kDa band representing the fusion protein was excised
and the protein was electroluted from the gel slices using a Schleicher
& Schuell Electro-Separation chamber. Approximately 300 ,tg of the
purified fusion protein were emulsified with Freund's complete ad-
juvant and injected intramuscularly and subcutaneously into a young
male New Zealand white rabbit. After 4, 6, 8, and 10 wk the rabbit
was boosted with -50 ,gg of the fusion protein in an emulsion with
Freund's incomplete adjuvant. Antisera were collected and screened
by immunoprecipitation.
Cell Labeling and Immunoprecipitations
For whole-cell radiolabeling, cells were grown in WiMPYE supple-
mented with the appropriate amino acids to an optical density (OD)
at 600 nm of 1. To initiate labeling, Tran35S label was added (at final
concentration of 150 mCi/ml) to cells at 10 OD600nm/ml in WiMP, 1
mg/ml bovine serum albumin and the cells were incubated 5 min at
30°C. When necessary, the labeling reaction was chased by adding
cold methionine to 10 mM for the appropriate amount of time. The
reaction was terminated by adding trichloroacetic acid to a final con-
centration of 5%. For labeling of spheroplasts (Vida et al., 1990), cells
were grown in WiMP as above. Zymolyase 100T 10 ,ig/2 X 107 cells
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were added, and the culture was incubated 30 min at 30°C. Sphe-
roplasts were washed in 1.2 M sorbitol and labeled as described above
in WiMP, 1.2 M sorbitol. The immunoprecipitations were as described
(Klionsky et al., 1988), except that three washes were performed: once
with buffer A (50 mM tris(hydroxymethyl)aminomethane [Tris]-HCl,
pH 7.5, 150 mM NaCl, 0.1 mM EDTA) containing 0.5% Triton X-
100, once with buffer A plus 2 M urea, and then again with buffer
A. Samples were separated in 10% SDS-polyacrylamide gels as pre-
viously described (Laemmli, 1970).
Subcellular Fractionation
SEY6210 (wild-type) cells were spheroplasted and labeled 5 min as
described above. The cultures were chased with cold methionine (10
mM) for 5 min, and the chase was stopped by diluting the labeled
culture in one volume of ice-cold WiMP and incubating it on ice for
5 min. The spheroplasts were sedimented 3 min at 500 X g, resus-
pended in 2 ml of lysis buffer (10 mM triethanolamine, pH 7.2, 0.8
M sorbitol, 1 mM EDTA) containing a protease inhibitor cocktail (1
mM phenylmethylsulfonylfluoride [PMSF], 50 ,g/ml leupeptin, 50
,ug/ml pepstatin A, 100 ,ug/ml a2-macroglobulin, 50 ,ug/ml antipain),
and dounced 20-25 times in a glass tissue homogenizer. The lysate
was centrifuged 3 min at 500 X g, and the unlysed spheroplasts were
reextracted in the same buffer. The combined supematants were cen-
trifuged 15 min at 13 000 X g to generate a pellet (P13) and a super-
natant (S13) fraction. Typically, 0.5-ml aliquots of the S13 fraction
were adjusted to the following concentrations of one of several re-
agents: lysis buffer, 1 M NaCl, 4 M urea, or 1% Triton X-100. Extracts
were incubated 10 min on ice and centrifuged 45 min at 100 000 X g.
The supernatant (S100) was removed and precipitated in 5% trichlo-
roacetic acid, the pellet (P100) was resuspended in 100 g1 boiling
buffer (50 mM Tris-HCl, pH 7.5, 1% SDS, 6 M urea, 1 mM EDTA).
The trichloroacetic acid precipitations were held on ice for 20 min
and then centrifuged 2 min at 13 000 X g. The trichloroacetic acid
pellets were washed twice with acetone, dried, and resuspended in
100 pl boiling buffer. The samples were then immunoprecipitated as
described above.
Sucrose Gradients with Vps35p
SEY6210 wild-type spheroplasts were labeled and lysed as described
above, except the chase period was for 30 min. After removing the
unlysed spheroplasts (3 min at 500 x g), the lysate was centrifuged
for 45 min at 100 000 X g. The pellet fraction was suspended in 2.5
ml 60% (wt/wt) sucrose, 50 mM Tris-HCl, pH 7.2, loaded on the
bottom of a 5-ml ultra-clear Beckman centrifugation tube, and overlaid
with 2.5 ml of 35% (wt/wt) sucrose, 50 mM Tris-HCl, pH 7.2. The
gradient was centrifuged for 18 h at 170 000 X g and was harvested
from top to bottom in 0.45-ml fractions. The fractions were precipitated
in 5% trichloroacetic acid and immunoprecipitated with the appro-
priate antisera as described above.
RESULTS
Cloning of the VPS35 Gene
Previously, we have described a selection procedure for
the isolation of vps mutants in yeast that exploited the
sorting behavior of a CPY-Inv hybrid protein (Bankaitis
et al., 1986; Robinson et al., 1988). In wild-type cells
(deleted for all endogenous genes encoding invertase,
Asuc), the targeting information contained in the CPY
portion of the fusion protein leads to efficient sorting
of the fusion protein to the vacuole (Johnson et al.,
1987). However, in vps mutant cells, the CPY-Inv hybrid
protein is mislocalized and secreted from the cell. The
secreted invertase activity leads to a selectable pheno-
type, the ability of these mutant cells to utilize sucrose,
an invertase substrate, as a sole carbon source (Bankaitis
et al., 1986; Robinson et al., 1988).
To clone the wild-type VPS35 gene, we devised a
simple plate overlay assay that directly tests single col-
onies for secretion of the CPY-Inv hybrid protein.
SEY35-17 (vps35-17 leu2-3,112) cells containing a CPY-
Inv fusion (pCYI-50) (Johnson et al., 1987) were trans-
formed with a yeast genomic library contained in a
pBR322-based LEU2/CEN4/ARS1 shuttle vector. Leu+
transformants were selected on SM glucose plates sup-
plemented with the appropriate amino acids. After 72
h, the transformants were replicated onto selective SM
fructose plates and incubated for 24-36 h. The replica-
plates were then overlaid with an invertase assay so-
lution containing 1.2% agar (see MATERIALS AND
METHODS). Invertase catalyzes the hydrolysis of su-
crose to glucose and fructose (Goldstein and Lampen,
1975). This activity can be easily detected by colorimetric
assays designed to quantitate the release of glucose from
sucrose hydrolysis (Bankaitis et al., 1986; Robinson et
al., 1988). Because yeast cells do not transport sucrose
across the plasma membrane, this enzyme assay detects
only the invertase activity that has been secreted from
the cells. Transformant colonies containing cells that
secreted the CPY-Inv hybrid protein produced glucose
and turned red after 5 min, indicating a Vps- phe-
notype, whereas transformants that restored normal lo-
calization of the hybrid protein to the vacuole (Vps+)
remained white for >30 min (Figure 1).
Among 35 000 Leu+ transformants assayed for CPY-
Inv hybrid protein secretion, 17 remained white after
the overlay assay, indicating that they represented po-
tential VPS35 gene clones. Plasmid DNA was extracted
from eight of these transformants and amplified in E.
coli. On retransformation, the plasmids restored intra-
cellular localization of the CPY-Inv hybrid protein in
strains carrying either of two different vps35 alleles. Re-
striction enzyme analysis of the complementing plas-
mids demonstrated that each contained largely over-
lapping genomic DNA inserts. A restriction map of the
smallest of these inserts, a 7.5-kb complementing frag-
ment, is shown in Figure 2A. Subcloning and comple-
mentation analysis localized the complementing activity
to a 3.5-kb Nci I/Sca I fragment. The complementing
Nci I/Sca I fragment (see Figure 2A) also was subcloned
into the 2,t vector pBHY10 to generate the plasmid
pGPY45. Yeast transformants harboring this plasmid
overproduced the VPS35 gene product .30-fold (see
below). Transformation of SEY35-17 or wild-type
strains with pGPY45 resulted in a Vps+ phenotype, and
growth rates of the strains were unaffected, indicating
that severalfold overproduction of the VPS35 gene
product was not detrimental to cell growth.
To confirm that the cloned genomic fragment con-
tained the VPS35 locus, a Nci I/Sca I fragment (Figure
2A) was subcloned into an integrative plasmid
(pPHYI10) containing the TRPI selectable marker. The
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Figure 1. Invertase plate assay to detect complemen-
tation of vps35-17 by the cloned VPS35 gene. The parental
strain SEY6210 (wild-type), the mutant strain SEY35-17
(vps35-17), the mutant strain SEY35-17 carrying plasmid
pGPY35 (vps35-17/pGPY35), and the deletion strain
GPY1 135 (Avps35) were streaked on SM glucose plates.
After incubation at 30°C for 72 h, the cells were replica
plated onto SM fructose. The replica plates were then
overlaid with an invertase assay solution containing 1.2%
agar. All the strains carried a plasmid encoding a CPY-
Inv fusion protein. Colonies secreting the fusion protein
turned red (indicating Vps- phenotype), whereas the oth-
ers remained white (indicating a Vps+ phenotype).
vps35-17
plasmid was linearized at an unique restriction enzyme
site within the VPS35 complementing fragment and was
used to transform BHY1 1 (VPS35 trpl) to Trp+. Trp+
transformants (BHY158) were then crossed with
BHY157 (vps35 trpl), and diploids were selected and
sporulated. Twenty tetrads were dissected and gave 2:
2 segregation of Trp+:Trp- and of Vps+:Vps-. Trp+ co-
segregated with Vps+ in every case, indicating that the
cloned DNA fragment mapped to the VPS35 locus.
Disruption of VPS35
To examine the phenotypic consequences of deleting
the VPS35 gene, we replaced a 2.45-kb SnaBI fragment
of the minimum complementing clone with the HIS3
gene (Figure 2B). An Nci I/Xba I fragment containing
this deletion construct was used to transform the pa-
rental diploid strain SEY6210.5, which is homozygous
for the his3-A200 mutation. Two independent His+
transformants were subjected to tetrad analysis. All four
spores from one tetrad were analyzed by Southern blot
to verify correct integration and subsequent segregation
of the deletion construct. Sixteen spores of four more
tetrads were transformed with the PRC1-SUC2 gene fu-
sion on a low copy-number plasmid Uohnson et al.,
1987) and assayed for secretion of the CPY-Inv hybrid
protein. As expected for the disruption of the VPS35
gene, a segregation pattern of two Vps- (CPY-Inv se-
creting), His+:2 Vps+ (CPY-Inv non-secreting), His-
spores was observed. After sequencing the minimum
complementing fragment (see below), we determined
that the deleted fragment comprised >85% of the VPS35
coding region (Figure 2B). As implied in the results
above, all haploid progeny were viable, and therefore,
the VPS35 gene is not essential for yeast cell growth or
spore germination. Also, Avps35 cells were viable at
37°C, consistent with the observation that none of the
32 previously isolated vps35 alleles results in a temper-
ature-sensitive growth defect.
To examine vacuolar morphology in the deletion
strain, Avps35 cells were stained with 5(6)-carboxy-2',7'-
dichlorofluoresceon diacetate to label the vacuoles
(Pringle et al., 1989). Strains harboring a disrupted vps35
gene invariably contained one to three large vacuolar
compartments similar to those observed in wild-type
cells or other vps35 mutants (Banta et al., 1988). There-
fore, the VPS35 gene product is not required for main-
taining the integrity or structure of the vacuole. More-
over, a vacuole was also observed in all newly forming
buds, indicating that vacuolar inheritance/segregation
is not affected in Avps35 mutants.
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Figure 2. Characterization and disruption of the VPS35 locus. (A)
Restriction map of the entire 7.5-kb VPS35 complementing fragment.
The black arrow represents the VPS35 open reading frame in an en-
largement of the 3.5-kb Nci I/Sca I VPS35 minimum complementing
fragment. Restriction enzymes are as follows: BamHI, B; Kpn I, K; Nci
I, N; Sca I, Sc; SnaBI, S. (B) VPS35 gene disruption/deletion. The VPS35
open reading frame was largely deleted by replacing a 2.45-kb SnaBI
internal fragment with the yeast HIS3 gene. The stippled arrow rep-
resents the HIS3 coding region. (C) Identification of the VPS35 tran-
script. Poly(A)+ RNA was separated on a formaldehyde-agarose gel,
transferred to GeneScreen, and probed with a [a-32P]labeled VPS35
DNA fragment internal to the coding sequence. Yeast rRNAs 18S and
28S were used as size markers.
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Sorting of native CPY in the wild-type strain, the
Avps35 mutant strain, and the Avps35 strain transformed
with the complementing plasmid pGPY35 also was ex-
amined. Spheroplasts of the appropriate strains were
labeled with Tran35S label for 5 min and chased for 60
min. The cultures were then fractionated into super-
natant and pellet fractions, and CPY was immunopre-
cipitated. In wild-type yeast cells, >95% of the newly
synthesized CPY was present as a 61-kDa mature spe-
cies in an intracellular fraction (Figure 3), indicating
correct localization to the vacuole. In contrast, Avps35
spheroplasts contained <5% of the CPY as the mature
species. The majority of the CPY was present as the
Golgi-modified 69 kDa (p2) precursor molecule, and
>90% of this p2CPY was secreted by the mutant cells
(Figure 3). This severe sorting defect was corrected by
introducing the complementing plasmid pGPY35 (CEN,
VPS35) into the Avps35 mutant strain (Figure 3).
To determine whether the protein sorting defect of
Avps35 cells extended to vacuolar proteins other than
CPY, we also examined the sorting of proteinase A
(PrA), proteinase B (PrB), and alkaline phosphatase
(ALP). As is shown in Figure 4, -80% of the vacuolar
membrane protein ALP was converted to the mature
enzyme (mALP) in the Avps35 strain, consistent with
proper delivery to the vacuole. Because of its retention
as an integral membrane protein, no detectable levels
of unprocessed precursor or mALP was found in the
extracellular media fraction. A limited defect in the
sorting and/or processing of ALP has also been ob-
served with several other vps mutants, such as vpsl5
(Robinson et al., 1988; Klionsky and Emr, 1989; Herman
et al., 1991), indicating that membrane-associated pro-
teins may be sorted to the vacuole by a pathway dif-
ferent from that utilized by soluble vacuolar proteins.
However, unlike vpsl5 mutants, which are defective in
the sorting and processing of all soluble hydrolases ex-
amined (CPY, PrA, and PrB), up to 80% of precursor
WT Avps35 VCSE
Fraction E E I E
p2CPY-
mCPY-am d -
WT Avps 35
Fraction j E Ej
proCPY -
mCPY --rn
%CPY 95
proPrA -
mPrA --
%PrA 95
proPrB
mPrB -m
_n-69
-61
<5 95
-48
am
-42
<5 80 20
-40
-37
em0 -31
%/0PrB 95 <5 95 <5
proALP-,,
mALP
_76
-72
3'oALP 95 <5 95 <5
Figure 4. Sorting and processing of the vacuolar enzymes CPY, PrA,
PrB, and ALP. Spheroplasts of the yeast strains SEY6210 (WT) and
GPY1135 (Avps35) were labeled with Tran35S label for 10 min and
then chased for 30 min with 10 mM cold methionine and 0.2% yeast
extract. Centrifugation at 13 000 X g for 5 min separated the cultures
into pellet (I, intracellular) and supematant (E, extracellular) fractions.
Protein levels in each fraction were determined by quantitative im-
munoprecipitation with the appropriate antisera. The approximate
molecular weights of the precursor (pro) and mature (m) forms of
CPY, PrA, PrB, and ALP are indicated (Stevens et al., 1982; Klionsky,
et al., 1988; Klionsky and Emr, 1989; Moehle, et al., 1989).
Figure 3. Intracellular sorting of CPY. Yeast spheroplasts were la-
beled with Tran35S label for 5 min and then chased for 60 min with
10 mM cold methionine. The labeled cultures were centrifuged for 5
min at 13 000 X g and separated into pellet (I, intracellular) and su-
pematant (E, extracellular) fractions. The level of CPY in each fraction
was assessed by quantitative immunoprecipitation. The strains used
were SEY6210 (WT), GPY1135 (Avps35), and GPY1135 harboring
pGPY35 (VPS35 CEN). The positions of p2CPY (69 kDa) and mature
CPY (mCPY; 61 kDa) are indicated.
PrA (proPrA) and - 80% of precursor PrB (proPrB) was
converted to the mature vacuolar forms in Avps35
spheroplasts after 30 min of chase (mPrA, mPrB) (Figure
4). The small portion of proPrA and proPrB found in
the extracellular media was secreted from Avps35 sphe-
roplasts at essentially the same rate as that seen for
p2CPY (proCPY). In addition, the maturation kinetics
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for PrA and PrB in Avps35 cells were also similar to
those seen in wild-type cells. Thus, although CPY sort-
ing was completely dependent on the VPS35 gene prod-
uct, the vast majority of proPrA and proPrB was ap-
parently properly sorted and processed in the absence
of the Vps35p.
These results differ somewhat from those seen in an
earlier study (Robinson et al., 1988). Far more proPrA
was originally reported to be missorted in vps35 mutant
cells. To rectify this discrepancy, the vacuolar protein
sorting defect of the vps35 mutant cells used in the orig-
inal study was compared with the sorting defect of the
Avps35 cells used in this study. In all cases the extent
of maturation of CPY, PrA, PrB, and ALP in cells car-
rying the original vps35 mutant allele was the same as
in cells carrying the disrupted allele. Unlike the growth
conditions used in the previous study, cells and sphe-
roplasts used here were propagated in minimal media
containing yeast extract before and after the labeling
period. This helped to preserve the metabolic integrity
and stability of the cells. The exclusion of yeast extract
during growth and chase periods, therefore, is likely to
have resulted in the exaggerated PrA maturation and
sorting defect seen in the earlier study.
VPS35 Sequence Analysis
The nucleotide sequence of the VPS35 minimum com-
plementing fragment was determined by sequencing a
series of nested exonuclease III generated deletion tem-
plates by the dideoxynucleotide chain termination
method. The complete nucleotide sequence of both
DNA strands was determined. The DNA sequence con-
tained one long open reading frame (ORF) of 2810 bp
that has the potential to encode a protein of 937 amino
acids with a predicted molecular weight of 108 344
(Figure 5). Upstream of the translational initiation co-
don, at position -50, a TATATAA element was iden-
tified that closely resembles the yeast consensus TA-
TAAA sequence for transcription initiation (Struhl,
1987). A sequence TAG . . . TAAG . . . TTT that
closely approximates the proposed yeast transcriptional
termination sequence according to Zaret and Sherman
(1982) was found starting 89 nucleotides downstream
of the ORF stop codon TAG (Figure 5). Northern anal-
ysis was performed using an internal fragment of the
VPS35 ORF as a probe to identify the VPS35 transcript.
Consistent with the ORF size predicted from the DNA
sequence, a RNA species of 3100 bases was detected
(Figure 2C).
Analysis of the deduced protein sequence indicated
that Vps35p is relatively hydrophilic and contains nine
potential N-linked glycosylation sites. No obvious
N-terminal signal sequence or membrane-spanning do-
mains were detected by hydropathy analysis. A com-
parison of the predicted protein sequence with se-
quences in the Genbank, EMBL, and NBRF databases
failed to detect any sequence similarities of obvious sig-
nificance (Lipman and Pearson, 1985; Pearson and Lip-
man, 1988). A search for sequence similarity using the
5' flanking sequence of the VPS35 gene revealed that
this sequence is identical to the 3' untranslated region
of the INOI gene (Dean-Johnson and Henry, 1989).
Using the TFASTA algorithm (Pearson and Lipman,
1988), it could be shown that the sequence overlap ex-
tended to the C-terminal amino acids of the Inol pro-
tein. Because the INOI locus has previously been
mapped to the left arm of chromosome X (Mortimer et
al., 1989), we conclude that the yeast VPS35 gene also
maps to chromosome X.
Identification of the Vps35 Protein
To characterize the VPS35 gene product, we prepared
a polyclonal antiserum against a trpE-Vps35 fusion
protein. A fragment encoding 178 amino acids (amino
acids 630-808 in Figure 5) of the VPS35 gene product
was cloned into a trpE expression vector (Dieckmann
and Tzagoloff, 1985) to generate an in-frame gene fu-
sion. On induction, E. coli cells carrying this trpE-VPS35
gene fusion produced a novel protein of 55 kDa. This
hybrid protein was purified and used to immunize rab-
bits, and the resulting antiserum was utilized in im-
munoprecipitation experiments to detect Vps35p. The
antibodies recognized a unique polypeptide of
-110 000 molecular weight from radiolabeled wild-
type yeast extracts (Figure 6, lanes 3-6). This protein
was -30-fold more abundant when the VPS35 gene
was present on a multicopy plasmid (Figure 6, lane 7)
and was not detected in a Avps35 strain (GPY1 135) or
by the preimmune serum (Figure 6, lanes 1 and 2, re-
spectively). These data indicated that the polyclonal
antiserum specifically recognized the protein product of
the VPS35 gene. Pulse-chase analysis indicated the
turnover rate for Vps35p is relatively slow; after a 60-
min chase, there was only a slight decrease in the
amount of labeled Vps35 protein present in wild-type
cells (Figure 6, lane 5). Cells also were labeled after
treatment with tunicamycin, an inhibitor of N-linked
glycosylation. The size of Vps35p was unaffected by
the drug, indicating that none of the nine potential sites
for N-linked carbohydrate modification are utilized
(Figure 6, lane 6) (The two minor protein species with
a faster mobility than Vps35p seen after tunicamycin
treatment were occasionally seen in cell extracts gen-
erated from Avps35 strains and, therefore, do not rep-
resent a Vps35p species.) This result, together with the
absence of any obvious N-terminal signal sequence or
transmembrane domains, suggests that Vps35p does not
enter the secretory pathway. Densitometric analysis of
the levels of Vps35p relative to CPY suggested that
Vps35p comprises -0.01% of total cell protein in ex-
ponentially growing yeast cells. The overproduction of
Vps35p did not interfere with processing and sorting
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1 CCCGGTGAATCGCTTAAACAAGCAAAGAACCGCCTTAGAAAATTTTTTAAGATTGTTGATTGGATTGCCTTCTCAAAACGAACTAAGATTCGAAGAGAGATTGTTGTAATCTCATTTCAA 120
121 CGACTCTCTTTTTCTTTTTTTGCCTACCTATAAAAAACAAGACATTCACCATTATCCTATTATCCCTTCCATCAATACATATACTTAACATAACGTTTATAAAAATTCAACTATCAACA 240
241 GTCTTTATATTTTTTTTTTTTCTTTTGAACTATTGCTCTTTGTCACTTCGTCTTAAAGGGGCGTTTTTTATTTTTTTTTTTTTTTTTCAGTTGAGGTAGATGCGAGAAAGTGCTGTATT 360
361 TATTCAAGGGCCACCTCAGTAAAGAGAAGAAAAGAGAG AAAAAGAAGGTGGTGTATGTG GACCACTCAACAAGGCCCAGTGAAGTTAATATATAACGATAAAAGGAGGAGGAC 480
481 GAGAAAGAAGAAGCTGAAAAACACA 505
506 ATGGCGTATGCGGACTCACCAGAAAATGCGATCGCTGTTATGAACCGGTGTCTATCTCAACACAAACTAATGGAATCATTACAGCATACTTCCATAATGTTGACCGAATTGAGAAATCCA 625
1 M A Y A D S P E N A I A V M N R C L S Q H K L M E S L Q H T S I M L T E L R N P 40
626 AACTTATCGCCGAAGAAATACTACGAACTTTATGTCATTATTTTCGACTCATTGACTAATCTATCTACGTACCTCATAGAAAACCATCCTCAAAATCACCACTTAGCTGATCTTTATGAG 745
41 N L S P K K Y Y E L Y V I I F D S L T N L S T Y L I E N H P Q N H H L A D L Y E 80
746 TTGGTTCAATATACCGGTAACGTGGTACCCAGGCTTTACTTGATGATCACAGTTGGGACCAGCTATCTCACTTTCAATGAAGCGCCCAAGAAGGAAATCTTAAAGGATATGATTGAGATG 865
81 L V 0 Y T G N V V P R L Y L M I T V G T S Y L T F N E A P K K E I L K D M I E M 120
866 TGTCGTGGTGTGCAAAACCCAATAAGAGGTTTGTTTTTACGCTATTATTTATCCCAGAGAACCAAAGAATTACTTCCGGAGGACGATCCGTCGTTTAACTCTCAATTTATTATGAATAAT 985
121 C R G V Q N P I R G L F L R Y Y L S Q R T K E L L P E D D P S F N S Q F I M N N 160
986 TTCATCGAGATGAACAAGTTGTGGGTGAGATTACAACACCAGGGGCCACTTCGTGAGAGGGAAACCAGAACACGTGAAAGAAAAGAGCTGCAAATTTTAGTGGGGTCTCAACTAGTACGT 1105
161 F I E M N K L W V R L Q H Q G P L R E R E T R T R E R K E L Q I L V G S Q L V R 200
1106 CTTTCGCAGATTATTGATGATAATTTCCAAATGTATAAGCAAGATATTCTTCCCACCATTTTGGAACAAGTCATACAATGTAGAGATTTAGTATCCCAAGAATATCTTTTGGACGTCATC 1225
201 L S Q I I D D N F Q M Y K Q D I L P T I L E Q V I Q C R D L V S 0 E Y L L D V I 240
1226 TGCCAAGTGTTCGCAGACGAGTTCCATTTGAAAACCTTGGATACTTTACTGCAAACTACTTTGCATTTGAACCCTGATGTTTCGATAAACAAGATTGTTCTCACTTTGGTCGATCGATTA 1345
241 C Q V F A D E F H L K T L D T L L Q T T L H L N P D V S I N K I V L T L V D R L 280
1346 AACGATTATGTTACAAGACAGTTGGAGGACGATCCAAACGCCACCTCCACGAATGCTTATTTAGATATGGACGTGTTTGGTACGTTCTGGGACTATTTGACCGTATTGAATCATGAAAGA 1465
281 N D Y V T R Q L E D D P N A T S T N A Y L D M D V F G T F W D Y L T V L N H E R 320
1466 CCAGATCTATCATTACAACAGTTTATTCCTCTAGTTGAGAGTGTGATTGTTTTAAGTTTGAAATGGTATCCTAATAATTTTGATAATTTGAACAAACTCTTTGAATTAGTCTTACAAAAA 1585
321 P D L S L Q Q F I P L V E S V I V L S L K W Y P N N F D N L N K L F E L V L Q K 360
1586 ACTAAGGATTATGGTCAGAAAAATATTTCTTTAGAGTCCGAGCATTTATTTTTGGTTCTGTTATCTTTCCAGAATAGTAAACTTCAGCTAACCTCATCGACCACTGCGCCACCAAACTCA 1705
361 T K D Y G Q K N I S L E S E H L F L V L L S F Q N S K L Q L T S S T T A P P N S 400
1706 CCAGTTACTTCGAAAAAGCATTTTATCTTTCAATTAATCTCCCAGTGCCAGGCTTACAAAAACATCCTGGCTTTGCAGAGCATTAGTCTACAAAAAAAAGTTGTCAATGAAATTATTGAC 1825
401 P V T S K K H F I F Q L I S Q C Q A Y K N I L A L Q S I S L Q K K V V N E I I D 440
1826 ATCTTAATGGATAGAGAAGTGGAAGAAATGGCCGATAATGATTCAGAATCGAAACTGCATCCTCCAGGGCATTCCGCTTATTTAGTTATTGAGGACAAACTCCAAGTTCAGCGCCTGCTT 1945
441 I L M D R E V E E M A D N D S E S K L H P P G H S A Y L V I E D K L Q V Q R L L 480
1946 TCAATCTGTGAGCCCTTAATAATATCAAGAAGCGGACCGCCCGCAAATGTTGCATCCTCGGATACAAATGTAGACGAAGTGTTTTTTAATCGACATGATGAAGAAGAATCCTGGATACTG 2065
481 S I C E P L I I S R S G P P A N V A S S D T N V D E V F F N R H D E E E S W I L 520
2066 GACCCAATACAGGAAAAGTTGGCACATTTGATTCATTGGATAATGAACACTACTTCTCGGAAACAAACAATGAAAAACAAAATTCAATTTAGCTTAGAAGCCCAATTGGAAATATTACTT 2185
521 D P I Q E K L A H L I H W I M N T T S R K Q T M K N K I Q F S L E A Q L E I L L 560
2186 CTTATTAAATCTTCGTTCATTAAAGGTGGCATCAATGTTAAATACACTTTTCCAGCAATAATCACAAATTTTTGGAAACTGATGAGGAAATGCCGTATGATACAAGAGTACCTTTTGAAA 2305
561 L I K S S F I K G G I N V K Y T F P A I I T N F W K L M R K C R M I Q E Y L L K 600
2306 AAAAGACCCGATAACAAGACGTTACTTTCCCATTATTCCAATCTTTTAAAGCAAATGTTTAAATTTGTTTCTCGTTGTATCAATGATATCTTTAATTCTTGCAACAACTCATGCACAGAT 2425
601 K R P D N K T L L S H Y S N L L K Q M F K F V S R C I N D I F N S C N N S C T D 640
2426 CTGATTCTGAAACTGAATTTACAATGTGCCATTCTAGCTGAGCAATTGCAATTAAACGAAATTTCATATGATTTTTTCTCACAGGCCTTCACAATATTTGAAGAGTCTCTAAGTGATTCA 2545
641 L I L K L N L Q C A I L A E Q L Q L N E I S Y D F F S Q A F T I F E E S L S D S 680
2546 AAGACTCAGTTACAGGCTTTAATATATATTGCTCAGTCTTTACAAAAGACAAGATCACTCTACAAAGAAGCTTATTATGATTCTTTGATTGTCAGATGCACACTCCATGGATCCAAATTA 2665
681 K T Q L Q A L I Y I A 0 S L Q K T R S L Y K E A Y Y D S L I V R C T L H G S K L 720
2666 TTAAAGAAACAAGACCAATGTCGTGCTGTTTATTTATGCTCCCACCTCTGGTGGGCAACGGAAATTTCAAATATTGGTGAGGAAGAAGGTATCACAGACAACTTCTACAGAGATGGTAAA 2785
721 L K K Q D Q C R A V Y L C S H L W W A T E I S N I G E E E G I T D N F Y R D G K 760
2786 CGGGTGTTAGAATGTCTACAAAGGTCTCTCCGTGTGGCGGATTCTATAATGGATAACGAACAGAGTTGTGAGCTAATGGTCGAAATATTAAATAGATGCCTCTACTATTTTATTCACGGG 2905
761 R V L E C L 0 R S L R V A D S I M D N E Q S C E L M V E I L N R C L Y Y F I H G 800
2906 GATGAGTCCGAAACTCATATATCGATAAAATACATCAATGGTCTGATCGAACTAATCAAAACAAACTTAAAATCGCTAAAACTAGAAGATAACAGTGCCTCTATGATTACCAACTCAATC 3025
801 D E S E T H I S I K Y I N G L I E L I K T N L K S L K L E D N S A S M I T N S I 840
3026 AGTGATTTGCACATCACCGGAGAAAATAATGTGAAGGCAAGCAGTAATGCTGACGATGGCTCTGTAATCACAGATAAGGAATCAAATGTTGCCATAGGATCGGATGGTACGTATATTCAA 3145
841 S D L H I T G E N N V K A S S N A D D G S V I T D K E S N V A I G S D G T Y I Q 880
3146 TTAAATACTCTGAACGGATCTTCCACGCTAATACGCGGAGTCGTAGCAACTGCTTCAGGTAGTAAATTACTGCACCAACTGAAGTATATCCCAATCCACCATTTTCGACGCACTTGTGAG 3265
881 L N T L N G S S T L I R G V V A T A S G S K L L H 0 L K Y I P I H H F R R T C E 920
3266 TACATTGAAAGTCAAAGAGAAGTTGACGATCGTTTCAAAGTCATATATGTATAG 3319
921 Y I E S Q R E V D D R F K V I Y V * 937
3320 TTAAATAACGTACTTGCTCTTCGTACATGCCCAAGATAAAAACTACACAAATAAAGCTAATAAAAATTTACCTAAAGAAGGATCATAGATTAAGTGGAAGGAAACTTGTACATAAT 3439
3440 TCGAGTTTATTTTCAACTAAGATATCAAGGATTGTTTACTATAAAAACACTTAATTGGGTAATTTCTATTTTTTACTTTTTTTCTGTGTTAAAAAAATGGGTCGCGCCAATGCGCTCACA 3559
3560 AATCTATTCTTATCCCTAACTTACATCTACATGTAAAGCGCCACTAAGAGAGCTATAGCTTATCATACATTTACATCAGGTAAAGTATCATTTTGGCCAGTGGATACGAATTTAATATAT 3679
3680 AATCTTTGCTTTCCCTTCGCTCTTAAATTCACCAAGCAAGTTTGTTAAGAAATAAAGGAAAGGGGGCTCAAAAACCGAATCAAGTAAGACAAGAAACATGGGGTACAGTAC 3790
Figure 5. Sequence of the VPS35 locus. The nucleotide sequence and the deduced amino acid sequence of the VPS35 are shown. Putative
transcription initiation and termination sequences are underlined.
of CPY or PrA. In addition, cells overproducing Vps35p Tran35S label and gently lysed by the addition of DEAE-
did not exhibit any other obvious phenotype, such as dextran under conditions that disrupt the plasma mem-
temperature-sensitive growth or sensitivity to osmotic brane but not internal organelles (Klionsky and Emr,
stress. 1990). After this lysis, Vps35p was found to be degraded
Protease protection experiments indicated that by exogenously added protease K, whereas the precur-
Vps35p is in contact with the cytosol. In these experi- sor forms of CPY, pl and p2, residing in ER and the
ments, DKY6224 (Apep4) spheroplasts were labeled with Golgi compartments, respectively (Stevens et al., 1982;
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Figure 6. Identification and characterization of the Vps35 protein.
Whole cells were labeled with Tran35S label for 5 min and chased for
the time indicated. Immunoprecipitations were performed with the
clarified cell extracts using preimmune serum (P; lane 2) or the Vps35p
immune serum (I; lanes 1 and 3-7). Copy number refers to the gene
dosage of VPS35 in the strains used: L is SEY6210 (single copy, lanes
2-6), A is GPY1 135 (no copy, lane 1), and H is GPY1 135 with plasmid
pGPY45 (multicopy, lane 7). Exposure time of lane 7 containing over-
produced Vps35p is only 1/10 of lanes 1-6. Where indicated (+),
Tunicamycin was added to 20 Ag/ml 15 min before radiolabeling
(lane 6). The position and size of Vps35p is indicated.
Franzusoff and Schekman, 1989), were resistant to pro-
teolysis. These results indicate that Vps35p is not se-
questered in the lumen of an intracellular organelle.
Subcellular Fractionation of the Vps35 Protein
Differential centrifugation techniques were used to more
precisely determine the intracellular location of Vps35p.
SEY6210 spheroplasts (single copy VPS35) were radio-
labeled, lysed under conditions that maintain the struc-
tural integrity of internal organelles, and the crude ly-
sates were spun at 500 X g to remove unlysed
spheroplasts. This supematant was centrifuged at
13 000 X g to generate a supematant (S13) and a pellet
(P13) fraction. The S13 supematant was spun at 100 000
X g to obtain another set of supernatant (S100) and
pellet (P100) fractions. The relative level of Vps35p in
each fraction was assayed by immunoprecipitation
(Figure 7, A and B). When wild-type cell lysates were
examined, a small portion of Vps35p (15%) was found
in the P13 pellet, but the majority of the protein (80%)
was sedimented only at 100 000 X g (Figure 7, A, lanes
1-4, and B). In contrast, a vacuolar membrane marker
protein, mALP, was found predominantly in the P13
fraction (Figure 7B). Under comparable conditions, the
P13 pellet has been shown to contain other intracellular
organelles, such as nuclei (Hurt et al., 1988) and mito-
chondria (Goud et al., 1988; Walworth et al., 1989). In-
terestingly, p2 CPY and Kex2p, which most likely reside
in a late Golgi compartment (Julius et al., 1984; Graham
and Emr, 1991), are mainly found in the P100 pellet
(Figure 7B). In addition to Golgi compartments, the P100
fraction has also been found to contain vesicular inter-
mediates that transit between secretory pathway or-
ganelles (Walworth et al., 1989). Thus, if Vps35p is as-
sociated with an organelle, possible candidates include
transport vesicles and the Golgi apparatus but, impor-
tantly, not the vacuole.
In a similar experiment, lysates of SEY6210 cells har-
boring the VPS35 gene on the multicopy plasmid
pGPY45 were separated into pellet and supernatant
fractions at 13 000 and 100 000 X g, and the distribution
of Vps35p was also determined (Figure 7, A, lanes 5-
8, and B). Unlike in the wild-type strain, the vast ma-
jority of Vps35p was found in the supernatant S100
fraction in cells overproducing this protein. Apparently,
Vps35p associates with only a limited number of sites
present in the P100 fraction. These interaction sites ap-
A
Single Copy Multicopy
Fraction F3 S13 P100 100 13 13 100 100
Vps35p- _
1 2 3 4 5 6 7 8
Protein P13 P100 S100
Vps35p (single copy) 15% 80% 5%
Vps35p (multicopy) 20% 10% 70%
ALP (vacuole memb.) 90% 10% <2%
Kex2p (late Golgi) 15% 85% <2%
p2CPY (late Golgi) 10% 65% 25%
G6PDH (cytosol) 5% 5% 90%
Figure 7. Subcellular fractionation of the Vps35 protein. (A) Sphe-
roplasts of SEY6210 (single copy VPS35, lanes 1-4) and GPY1135
harboring plasmid pGPY45 (multicopy VPS35, lanes 5-8) were labeled,
osmotically lysed, clarified (500 X g), and separated into pellet (P13)
and supematant (S13) fractions by centrifugation at 13 000 X g. A
portion of the S13 fraction was then centrifuged at 100 000 X g to
generate a second set of pellet (P100) and supematant (S100) fractions.
Vps35p was isolated by immunoprecipitation. The exposure time for
lanes 1-4 was 120 h. The exposure time for lanes 5-8 was 15 h. (B)
Quantitation of the amount of Vps35p and subcellular marker proteins
present in the cell fractions described in A. The marker proteins include
alkaline phosphatase (ALP), the Kex2 protease (Kex2p), the Golgi
modified precursor of CPY (p2 CPY), and glucose-6-phosphatase de-
hydrogenase (G6PDH).
B
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pear to be saturated in strains that overproduce Vps35p,
and the excess Vps35p remains in the 100 000 X g su-
pernatant.
The nature of the association of Vps35p with the par-
ticulate fraction P100 was investigated by treating the
S13 fraction containing the Vps35p with various re-
agents for 10 min at 4°C: 1 M NaCl, 4 M urea, and 1%
Triton X-100. The lysates were then centrifuged at
100 000 X g for 45 min, and the pellet and supernatant
fractions were assayed for the presence of Vps35p by
immunoprecipitation (Table 2). High salt concentrations
and urea extracted 95 and 90% of Vps35p from the
particulate fraction, respectively. These findings suggest
that ionic and hydrophobic interactions may stabilize
the association of Vps35p with a pelletable structure.
In addition, treatment of the cell lysates with Triton X-
100 also solubilized the vast majority of the particulate
Vps35p, indicating that Vps35p may be associated with
a cellular membrane fraction.
To further address the role of membranes in the as-
sociation of Vps35p with the P100 fraction, the parti-
tioning of Vps35p with cellular membranes was ex-
amined using sucrose density gradients. Sucrose
gradients can separate organelles and membranous
structures on the basis of their equilibrium density. This
approach has been used successfully to localize proteins
to particular compartments in the secretory pathway
(Walworth et al., 1989). We used a simple two-step su-
crose gradient to establish whether Vps35p is associated
with any organellar membrane. In this experiment
spheroplasts generated from wild-type cells were ra-
diolabeled and lysed. After removal of unbroken cells
at 500 X g, the lysate was separated into pellet and
supernatant fractions at 100 000 X g for 45 min. The
pellet was resuspended in 60% sucrose and overlaid
with a 35% sucrose solution. After centrifugation of the
gradient at 170 000 X g for 18 h, fractions were collected
and the amount of Vps35p and the vacuolar membrane
marker ALP in each fraction was determined by im-
munoprecipitation. ALP migrated to the top of the 60%
sucrose layer and into the 35% sucrose layer (Figure 8).
The same result was found for a membrane protein of
Table 2. Characterization of the particulate Vps35 protein'
Treatment SlOOb (%) p100b (%)
Control <5 95
1 M NaCl 95 <5
4MUrea 90 10
1% Triton X-100 95 <5
' The relative levels of the Vps35 protein in the P100 and S100 sub-
cellular fractions were determined after the treatment of wild-type
clarified cell lysate with the reagents listed above. See Figure 7 and
text for complete experimental details.
b Percent recovery of Vps35p in the S100 vs. P100 fraction.
% Sucrose: 35%0 60%
Fraction#: 1 2 3 4 5 6 7 8 9 10 1 1
Vps35p- , **t
ALP- _-
Top Bottom
Figure 8. Localization of Vps35p in a two-step sucrose gradient.
Labeled SEY6210 spheroplasts were lysed and spun at 500 X g to
remove unbroken cells. The clarified extracts were centrifuged at
100 000 X g for 45 min and yielded a pellet and a supematant fraction.
The pellet fraction was resuspended in 2.5 ml 60% sucrose, loaded
on the bottom of a Beckman ultra-clear centrifuge-tube, and overlaid
with 2.5 ml 35% sucrose. The sample was spun at 170 000 X g for
18 h and harvested from top (fraction 1) to bottom (fraction 11) in
0.45-ml fractions. Vps35p and alkaline phosphatase (ALP) were iso-
lated from each gradient fraction by quantitative immunoprecipitation
with the appropriate antisera.
a late Golgi compartment, Kex2p. In similar experiments
membrane proteins of other organelles, such as the
plasma membrane ATPase, Sec4p (a protein located on
the cytoplasmic surface of secretory vesicles), and mi-
tochondrial cytochrome c-oxidase, were shown to mi-
grate out of the 60% sucrose solution into fractions of
lesser density (Goud et al., 1988; Walworth et al., 1989).
A small portion of Vps35p remained in the 60% sucrose
layer, unaffected by the centrifugation. However, most
of Vps35p migrated out of the 60% sucrose solution
and into the 35% sucrose layer similar to ALP. Thus,
the results from the fractionation studies suggest that
Vps35p is associated with an intracellular membrane,
most likely as a component of a large multiprotein com-
plex.
DISCUSSION
To gain a better understanding of the role the VPS35
gene product plays in vacuolar protein sorting, the
VPS35 gene was cloned, its protein product analyzed,
and the phenotypic consequences of a vps35 null allele
were assessed. Several VPS genes have been isolated
by complementation of a temperature-sensitive growth
defect associated with certain vps mutants (Banta et al.,
1990; Herman and Emr, 1990; Herman et al., 1990;
Rothman et al., 1990). However, none of the 32 origi-
nally isolated vps35 alleles result in a temperature-con-
ditional growth defect, so an alternative assay was de-
vised to isolate the VPS35 gene from a yeast vacuole
(Bankaitis et al., 1986; Robinson et al., 1988). However,
vps mutants do not sort the CPY-Inv fusion protein to
the vacuole but instead secrete the hybrid from the cell.
This extracellular invertase activity can be easily de-
tected by overlaying mutant yeast colonies with a soft
agar solution containing reagents that detect invertase
activity. Using this simple assay, we were able to identify
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a yeast genomic clone capable of complementing the
CPY-Inv mislocalization phenotype associated with
vps35 cells and have shown that the complementing
DNA fragment contains the VPS35 gene. Recently, sev-
eral other VPS genes have been isolated with the help
of this assay (Horazdovsky and Emr, unpublished data;
Koehrer and Emr, unpublished data; Gharakanian and
Emr, unpublished data), and we believe that this method
will be useful for cloning many other genes that regulate
the intracellular sorting or retention of proteins in the
secretory pathway.
Some insights into the possible function of Vps35p
were provided by subcellular fractionation studies.
Several lines of evidence indicate that Vps35p resides
in the cytoplasm of the yeast cell as part of a membrane
associated, multiprotein complex. 1) Vps35p sediments
with a particulate fraction isolated from yeast lysates.
2) The VPS35 gene product does not contain an obvious
signal sequence or transmembrane domains and N-
linked carbohydrates are not added to Vps35p, even
though it has nine potential sites for N-linked glycos-
ylation. 3) Vps35p is degraded by protease added ex-
ternally to intact organelles isolated from gently lysed
spheroplasts and is, therefore, not sequestered in the
lumen of an organelle. 4) Vps35p is released from the
particulate fraction by several reagents, including urea
and high salt, that disrupt protein-protein interactions,
and is also released by treatment with Triton X-100. 5)
Vps35p has been shown to partition with cellular mem-
branes in sucrose gradients. Based on these observations,
we conclude that Vps35p's association with the high-
speed pellet results from interactions with a membrane
associated protein or protein complex. Interestingly, the
interaction of Vps35p with the particulate fraction is
saturable. In wild-type yeast cells, Vps35p is largely
pelleted at 100 000 X g (80%), whereas in cells over-
producing Vps35p, the vast majority remains in the su-
pernatant fraction (Figure 7). This observation indicates
that the association site(s) for Vps35p is specific and
limiting. The exact composition of the Vps35p associ-
ation complex is unknown but probably includes other
proteins, as overproduced Vps35p fractionates as a sol-
uble protein. Attempts to localize Vps35p in wild-type
cells using indirect immunofluorescence techniques
have failed thus far. In a strain overproducing Vps35p,
only cytoplasmic staining was observed, supporting the
finding that in these cells most of the overexpressed
Vps35p is in the soluble fraction.
Unexpectedly, our analysis of the vacuolar protein
sorting defects in Avps35 mutants indicates that Vps35p
function may only be required for the sorting of a small
subset of soluble vacuolar proteins. Even though Avps35
cells contain a morphologically wild-type vacuole, CPY
sorting is almost completely blocked in the vps35 null
mutant; >95% of CPY is secreted as its Golgi modified
p2 precursor form (proCPY, Figure 4). However, the
vast majority of two other soluble proteases, PrA and
PrB, are retained and matured in Avps35 mutant cells
(Figure 4). This result indicates that CPY sorting is com-
pletely dependent on the presence of functional Vps35p.
Yet, the sorting and processing of other soluble proteases
(PrA and PrB) can occur in a Vps35p-independent
manner. Apparently, only a subset of soluble vacuolar
proteins, like CPY, may require Vps35p for their efficient
sorting to the vacuole.
We provide three possible models to explain the
Vps35p dependent/independent sorting of soluble
vacuolar hydrolases. First, soluble vacuolar proteins
could use two (or more) completely independent deliv-
ery systems. In vps35 mutant cells, the specific sorting
system responsible for vacuolar delivery of CPY and
presumably other unknown proteins would be inacti-
vated, yet an independent PrA and PrB delivery system
would remain intact. As a result, CPY would be secreted
from the cell, whereas PrA and PrB would be delivered
to the vacuole and converted to their mature forms. The
presence of completely independent systems for the lo-
calization of different subsets of vacuole proteins cannot
be ruled out. However, because a number of vps mutants
mislocalize CPY, PrA, and PrB to the same extent (Rob-
inson et al., 1988; Herman et al., 1991; Horazdovsky,
and Emr, unpublished data), truly independent delivery
systems seem unlikely. In the second model, the active
sorting of soluble vacuolar proteins may involve a single
receptor complex that is required for the recognition of
all soluble vacuolar proteins. This receptor complex
could possess different affinities for soluble vacuolar
proteins (high affinity for proPrA and proPrB but a lower
affinity of proCPY), or, alternatively, different vacuolar
proteins may occupy the receptor compartment for dif-
fering periods of time providing some proteins increased
access to the receptor (such as proPrA and proPrB). If
receptor complexes were to become limiting (in the ab-
sence of Vps35p) then proCPY, being unable to effi-
ciently compete for receptor binding, would be secreted
from the cell. This seems unlikely, however, as it has
been shown previously that overexpression of PrA does
not result in the missorting or secretion of CPY (Roth-
man et al., 1986). If a single receptor complex with
a higher affinity for PrA than for CPY is involved in
the sorting pathway, the overexpression of PrA would
be expected to result in the secretion of CPY. This is
not the case. In addition, the near normal maturation
kinetics of PrA and PrB in Avps35 cells (as well as the
similar secretion rates for p2CPY and the small amount
of proPrA and proPrB that are secreted in this mutant)
further indicate that the delivery of PrA and PrB is
largely unaffected by the loss of VPS35 gene product
function and a longer residence time in the proposed
sorting compartment cannot account for their vacuolar
delivery. Finally, in the third model, CPY, PrA, and PrB
could use the same transport system (vesicle carriers)
to mediate their Golgi to vacuole delivery but may utilize
different membrane receptors for their selective pack-
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aging into a common carrier. One receptor complex may
recognize CPY, whereas a second receptor complex may
recognize PrA and PrB. Though Vps35p does not re-
semble a receptor molecule, it may play a role in the
function, modification, or packaging of the CPY-specific
receptor complex. Loss of Vps35p function would in-
activate the CPY-specific receptor and result in default
secretion of CPY. PrA, PrB, and ALP localization would
be largely unaffected in this model, as their delivery
would depend on a different receptor complex(es).
Present data are most consistent with this final model.
Direct proof for the role of multiple receptor complexes
in this protein-sorting process will require the identifi-
cation of these complexes. Unfortunately, no good can-
didate for a receptor molecule has yet been identified
among the presently characterized VPS gene products.
To learn more about the detailed biochemical function
of Vps35p, we plan to assay its role in a recently de-
veloped in vitro reconstitution assay for vacuolar protein
sorting (Vida et al., 1990), as well as identify cellular
components that interact with the VPS35 gene product
using both genetic and biochemical approaches.
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